Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition use...

Por Norwood, Paul, Chen, Roger, Jaeckel, Elmar, Lingvay, Ildiko, Jarlov, Henrik, Lehmann, Lucine, Heller, Simon
Publicado no Diabetes Obes Metab (2017)

A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers: Applicability of a novel insulin-independent treatment

Por Wilding, John P.H., Norwood, Paul, T'joen, Caroline, Bastien, Arnaud, List, James F., Fiedorek, Fred T.
Publicado em 2009

Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type...

Por Warren, Mark L., Chaykin, Louis B., Jabbour, Serge, Sheikh-Ali, Mae, Hansen, Charlotte T., Nielsen, Thor S.S., Norwood, Paul
Publicado no Clin Diabetes (2017)

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial

Por Wysham, Carol, Bhargava, Anuj, Chaykin, Louis, de la Rosa, Raymond, Handelsman, Yehuda, Troelsen, Lone N., Kvist, Kajsa, Norwood, Paul
Publicado no JAMA (2017)

Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial

Por Rodbard, Helena W, Lingvay, Ildiko, Reed, John, de la Rosa, Raymond, Rose, Ludger, Sugimoto, Danny, Araki, Eiichi, Chu, Pei-Ling, Wijayasinghe, Nelun, Norwood, Paul
Publicado no J Clin Endocrinol Metab (2018)